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1. Introduction 
Phosphofmctokinase* has been isolated from 
several mammalian tissues in highly purified or even 
crystallized forms [l-6] . Human PFK received 
greater attention when a new human disease was 
detected, which could be characterized by a deficiency 
of muscle PFK and a decrease of the enzyme in red 
blood cells to about 50% of normal. These findings 
led to comparative studies of various properties of 
both enzymes, which revealed characteristic differences 
between them [7-91 . In these studies only partially 
purified erythrocyte PFK with a specific activity of 
12wasused [7]. 
Recently, we described the occurrence of various 
oligomeric forms of human erythrocyte PFK, and 
determined the molecular weights of their SDS 
cleavage products [lo] . 
In this paper the procedure for getting a highly 
purified, stable and homogeneous human erythrocyte 
PFK preparation with a specific activity of about 130 
is described. Some special properties of the enzyme are 
also presented. 
2. Materials and methods 
PFK activity was measured in the coupled optical 
test at 25” [lo] . Enzyme activity is given in Inter- 
national Units (IU), defined as pmoles FDP formed 
per min in the standard assay. 
Protein concentrations were determined according 
to [ 1 l] with human serum albumin as a standard or 
*Abbreviations: 
F6P, fructose 6-phosphate; FDP, fructose-1,6diphosphate; 
PFK, phosphofructokinase; SDS, sodium dodecylsulphate. 
North-Holland Publishing Company - Amsterdam 
spectrophotometrically at 280 nm [ 121 . Hemoglobin 
was measured by the cyanmethemoglobin method 
[131’ 
3. Results 
3.1. Purification procedure 
The following method describes the preparation of 
PFK from human red blood cells obtained from a 
blood bank. At least the first steps of the method are 
similar to the procedure of Layzer et al. [7]. However, 
the ionic composition and pH of various media were 
changed as a result of numerous experiments to im- 
prove enzyme stability and efficiency of the prepara- 
tion procedure. In our experience the yield, purity 
and stability of the final preparation are dependent 
on the first purification steps, thus these are therefore 
described in detail. All operations were carried out at 
O-2” unless otherwise indicated. The blood was cen- 
trifuged and the erythrocytes were washed 3 times 
with 0.9% NaCl. In general, all potassium phosphate 
buffers used in the subsequent steps contained 10 
mM ammonium sulphate, 1 mM EDTA, 0.5 inM FDP, 
0.1 mM ATP and 5 mM mercaptoethanol. 
3.1 .l. Step 1: Hemolysis 
The washed erythrocytes were mixed with an 
equal volume of 10 mM phosphate buffer @H 8.0) 
and stirred for one hr. After that the stroma was 
removed by centrifugation (15,000 g, 30 min). 
3.1.2. Step 2: Adsorption on DEAE-cellulose 
DEAE-cellulose (50 g/l hemolysate) equilibrated 
with 10 mM phosphate buffer @H 8.0) was poured 
into the stroma-free hemolysate and stirred for an 
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Table 1 














1. Hemolysate 4800 1920 585,000 
2. Batch DEAE-cellulose 1410 1560 5,250 
3. Ammonium sulphate fractionation 240 1460 1,620 
4. Heat treatment 230 1310 350 
5. Sephadex G-200 3.5 1080 54 
6. Sepharose 4 B 1.5 970 7.1 
- -- -- 
* The specific activity of the enzyme in the hemolysate is referred to hemoglobin. 
0.003 * 1 100 
0;3 100 81 
0.9 300 76 
3.7 1,230 68 
20 6,700 56 
136 44,000 51 
additional hr. Thereafter the DEAE-cellulose was about one tenth of that of the erythrocyte sediment. 
separated by centrifugation and washed several times To this solution, solid ammonium sulphate was again 
with 10 mM and 50 mM phosphate buffer to remove added to a final saturation of 0.25. After 30 min the 
hemoglobin. The enzyme was eluted from DEAE- precipitate was removed by centrifugation and dis- 
cellulose with 250 mM phosphate buffer. carded. 
3.1.3. Step 3: Ammonium sulphate fractionation 3.1.4. Step 4: Heat treatment 
Solid ammonium sulphate was slowly added to the The supernatant was rapidly heated with stirring in 
eluate from the DEAE-cellulose to a final saturation a jacketted vessel to 65” and kept at this temperature 
of 0.45 adjusting the pH to 8.0 with 1 M ammonia. for 30 mm. After rapidly cooling to 0' , the suspension 
The suspension was stirred for 30 min and after centri- was centrifuged at 26,000 g, the precipitate discarded, 
fugation (26,000 g, 30 min) the precipitate was dis- and ammonium sulphate added to the supernatant to 
solved in 100 mM phosphate buffer to a volume of 0.45 saturation. After 30 min, the precipitate was col- 
i’/ Incubation time 30min 
1 , I I I I I I , I I 
50 60 
Temperature EC, 7o 
r Temperature 65% 
1 I 0 I a 1 
20 LO 60 
Time [min] 
60 
Fig. 1. Stability of erythrocyte phosphofructokinase as functions of temperature and time. (A) Dependence on temperature, in 
cubation time 30 min, and (B) dependence on time at 65”. a--a specific activity, - enzyme yield. 
282 
Volume 19, number 4 FEBS LETTERS January 1952 
Fig. 2. pH-dependence of erythrocyte phosphofructokinase 
activity. - imidazole/HCl buffer, - Tris/HCl buffer, 
- Veronal-Na buffer. 
lected by centrifugation at 26,000 g and redissolved 
in a small volume of 100 mM phosphate buffer. In- 
soluble residues were removed by centrifugation. 
3.15. Step 5: Sephadex G-200 chromatography 
The enzyme solution was applied to a column (100 
X 5 cm) of Sephadex G-200 equilibrated with 100 mM 
phosphate buffer pH 7.0 containing 2 n&l F6P in- 
stead of ATP and eluted with the same buffer. PFK 
activity appeared in the first of three protein-con- 
taining peaks. The main fractions with PFK activity 
were pooled, and the enzyme precipitated by adding 
solid ammonium sulphate to a saturation of 0.45. 
After centrifugation at 26,000 g, the enzyme was 
redissolved in a small volume of phosphate buffer. 
3.1.6. Step 6: Sepharose 4B chromatography 
The enzyme solution was applied to a column of 
Sepharose 4B (70 X 2.5 cm) equilibrated with the 
same phosphate buffer as in step 5. During elution 
PFK activity appeared in several separate peaks [lo]. 
The pooled main fractions were concentrated by 
precipitation of the enzyme with ammonium sulphate 
at 0.45 saturation. The precipitate was collected by 
centrifugation and redissolved in a minimum volume 
of 100 mM phosphate buffer pH 8.0. 
A summary of a typical preparation of PFK from 
2400 ml erythrocyte sediment is shown in table 1. 
The final specific activity of the purified enzyme was 
136 units per mg protein. The purification factor was 
about 44,000 with 50% yield. The specific activities 
from other preparations ranged from 120- 150 units 
per mg protein. As judged by SDS-electrophoresis, 
the final preparation appeared to be homogeneous. 
It showed only one band having a molecular weight of 
104,000 under dissociating conditions [lo] . 
3.2. Some properties of the enzyme 
The purified enzyme (7-12 mg protein per ml) if 
stored in a medium containing 100 mM potassium 
phosphate (pH 8.0), 10 mM ammonium sulphate, 1 
mM EDTA, 5 mM mercaptoethanol, 0.5 mM FDP, 4 
mM 5’AMP or 4 mM ATP is stable at 0” for at least 3 
weeks. 
Heat stability of the enzyme at step 4 was studied 
in a medium containing 100 mM potassium phosphate 
(pH 8.0), 1 mM EDTA, 5 mM mercaptoethanol, 0.5 
mM FDP, 0.1 mM ATP and 0.25 saturation with 
ammonium sulphate. The results of these experiments 
are presented in fig. 1, A and B. In the purification 
procedure the results of these 2 experiments were 
combined leading to a high efficiency of the heat treat- 
ment. 
Purified erythrocyte PFK has been found to be free 
of other glycolytic enzymes as well as of glucose-6- 
phosphate dehydrogenase, adenylate kinase, ATPase 
and NADH oxidase. At 1 mM F6P and 0.25 mM ATP 
the enzyme shows a broad pH-optimum between 7.6 
and 8.4 (fig. 2). This is in agreement with the pH- 
activity curve of rat erythrocyte PFK [ 141 . 
4. Discussion 
The procedure described allows the preparation of 
highly purified homogeneous PFK from human erythro- 
cytes, devoid of other glycolytic enzyme activities 
and having a specific activity of 120-150. These 
values are comparable to those of homogeneous and 
crystallized preparations from other mammalian 
tissues. The crucial point of the present procedure 
seems to be the heat treatment of the enzyme (step 4). 
In the procedure of Layzer et al. [7] a considerable 
loss of enzymatic activity occurs upon heat treatment 
of the enzyme with a negligible increase in specific 
activity. In our experience, the results of heating the 
enzyme can be improved by addition of ammonium 
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sulphate and FDP. The optimal concentrations of 
these solutes have been tested and included in the 
purification scheme. 
In Sepharose 4B chromatography the enzyme is 
eluted in several fractions. As has been shown, these 
differ in their molecular weights [lo] . After cleavage 
of these forms with SDS. all of them can be traced 
back to a subunit having’s molecular weight of 
104,000 [lo]. Until now, this SDS-cleavage product 
seems to be the common subunit of all oligomeric 
forms of erythrocyte PFK separable by Sepharose 4B 
chromatography. 
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